Nimodipine (Nimotop)

Nimodipine is an approved drug for preventing certain neurological problems in people who have experienced a brain haemorrhage. It is being studied as a treatment for HIV-associated dementia.

The most frequent side-effect of nimodipine is decreased blood pressure. It may also cause heart irregularities, flushing, headache, gastrointestinal disorders, nausea and a feeling of warmth.

It comes either as yellow tablets or a liquid for intravenous infusion. It is manufactured by Bayer under the tradename Nimotop.

Up a level
Back to contents
This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.